Related by context. All words. (Click for frequent words.) 89 Drug Discovery AIDD 68 Idera Pharmaceuticals develops 67 Micromet proprietary BiTE 66 PORxin TM 66 Locked Nucleic Acid LNA 66 motexafin gadolinium Injection 66 Angiocept 66 Synavive ™ 66 Prednisporin 66 Maxy G# 65 TOCOSOL 65 Xcytrin R 65 Locked Nucleic Acid 65 CB2 selective 65 molecular imaging radiopharmaceutical 65 Pepducin 65 PNP inhibitor 65 candidate REP# 65 muscarinic receptor agonist 65 Cardio Vascu Grow 65 proprietary PharmacoSurgery ™ 65 Adnectin 65 targeted radiotherapeutic 65 CB2 selective receptor agonist 65 Nanobody 64 PDE4 inhibitor 64 Nanobody ® 64 Stapled Peptide 64 candidate deforolimus 64 novel anti infective 64 anti botulism antibody 64 adrenergic regulation 64 THR beta agonist 64 rxRNA 64 LymphoStat B TM 64 polymer conjugate technology 64 using VIAdel TM 63 Speedel develops 63 proven DuraSite ® 63 Prednisporin TM 63 Initiates Enrollment 63 AAG geldanamycin analog 63 Aganocide 63 HepDirect R 63 ionotropic glutamate receptor antagonists 63 Anticalin 63 skeletal sarcomere activators 63 Plexxikon proprietary 63 Small Modular SMIP 63 M# rationally 63 XmAb ™ 63 therapeutic monoclonal antibody 63 Nasulin ™ 63 bioadhesive polymer core 63 ZFP Therapeutics 63 lead molecular radiotherapeutic 63 novel L DOS# 63 Alfacell proprietary ribonuclease 63 nitric oxide donating 63 selective immunoproteasome inhibitor 62 HuMax CD#b 62 delivery polymer matrix 62 Archexin 62 Supernus Pharmaceuticals 62 clinical trials dacetuzumab SGN 62 Oral NKTR 62 pipeline GlycoPEG GCSF 62 Fleximer 62 Akesis Pharmaceuticals 62 oncolytic virus therapies 62 ABL inhibitor 62 epothilones 62 PORxin 62 DOS# 62 Annamycin 62 oral prodrug 62 pepducin 62 Personalized Immunotherapy 62 CYT# vascular disrupting 62 TELINTRA R 62 Memryte 62 SinuNase ™ 62 radiation sensitizer 62 Affilin ® 62 Novolimus 62 Pentad TM 62 IMiDs R 62 Intermezzo ® zolpidem tartrate 62 novel immunomodulatory 62 ALTROPANE R 62 IMPDH inhibitor 62 oral taxane 62 specific protein tyrosine 62 developing TB4 62 multi kinase inhibitor 62 Nektar proprietary 62 XmAb 62 commercialize CorMedix drug 62 proprietary LNA 62 Myocet 62 Spiegelmer ® 62 molecular imaging radiopharmaceuticals 61 taxane derivative 61 PEGylation technology 61 OMP #R# 61 topical dermatology 61 Ambrx 61 investigational pan BCR 61 Cannabinor 61 IAP inhibitors 61 PROfusion 61 intranasal insulin product 61 Initiates Phase II 61 active cellular immunotherapy 61 Dyax phage display 61 agent bevasiranib 61 Auxilium transmucosal film 61 Pimavanserin 61 HGS# 61 MKC# MKC# PP 61 Aganocide ® 61 PDE4 modulators 61 Captisol ® 61 Pancreate 61 metaglidasen 61 IMiDs ® 61 TRIOLEX ™ 61 SynCon TM DNA 61 Vaccinex 61 JZP 61 Micromet BiTE 61 Nasdaq ACHN 61 Anavex #-# 61 PORxin TM platforms 61 BHT DNA 61 Celator 61 erlotinib Tarceva R 61 Sangamo ZFP technology 61 Inc. Nasdaq NEXM 61 Begins Dosing 61 selective orally bioavailable 61 seliciclib CYC# 61 reformulates existing FDA 61 platinum chemotherapeutic 61 Initiates Clinical 61 XmAb ® 61 UltiMAb 61 Spiegelmer 61 R roscovitine 61 Factor VIIa 61 Curaxin 61 hypoxia activated prodrug 61 synthetic anti infective 61 Onconase 61 orally bioavailable 61 topically delivered 61 sapacitabine CYC# 61 Presents Preclinical Data 60 CCR9 antagonist 60 Files IND 60 drug GLPG# 60 Alexza Staccato 60 utilizes InSite Vision 60 TRIOLEX HE# 60 immatics 60 Serdaxin ® 60 Panzem 60 NEUGENE antisense 60 HIV integrase inhibitors 60 investigational humanized monoclonal antibody 60 HuMax TAC 60 include Phenoptin TM 60 Iluvien ® 60 lintuzumab SGN 60 small molecule tyrosine 60 defensin mimetic antibiotic 60 aldehyde dehydrogenase ALDH2 deficiency 60 Kosan dependence 60 bioengineered novel 60 thrombin component 60 Exelixis compounds 60 oral Janus kinase 60 Panzem NCD 60 L Annamycin 60 Sphingomab TM 60 Selective Electrochemical Tumor Ablation 60 Squalamine 60 PDE# inhibitors 60 proprietary phage display 60 XL# anticancer compounds 60 SAR# [002] 60 PsychoGenics 60 investigational protease inhibitor 60 anticancer therapeutics 60 OXIGON TM 60 IMA# 60 JAK2 inhibitor 60 proprietary HuCNS SC 60 liposomal delivery 60 Phase #b/#a clinical 60 oral Factor Xa 60 Solazed TM 60 Bioral 60 Fleximer R 60 sumatriptan DosePro 60 TLR9 agonist 60 XmAb TM 60 triggers apoptosis programmed 60 Epothilones 60 BiTE R 60 Potelligent Technology 60 targeting CD# 60 concerning CombinatoRx 60 BiTE 60 oral immunomodulatory 60 boron chemistry 60 Acetavance TM intravenous acetaminophen 60 VitiGam 60 candidate CRLX# 60 Thiarabine 60 POTELLIGENT ® 60 Chimigen 60 INxin TM 60 Reports Preclinical Data 60 Pertuzumab 60 OMP #M# 60 TÎ ² 4 60 integrative pharmacology 60 Completes Patient Enrollment 60 selective S#P# receptor agonist 60 intranasal formulation 60 HepeX B 60 AN# novel 59 overactive bladder AA# 59 Fc fusion protein 59 orally inhaled migraine 59 TM Aganocide 59 Aflibercept 59 allosteric modulator 59 highly selective inhibitor 59 Avila Therapeutics 59 Zoraxel TM 59 oral salmon calcitonin 59 innovative signaling pathway 59 P#X# antagonist 59 psoriasis rheumatoid arthritis 59 SPL# Gel vaginal microbicide 59 GPR# agonists 59 Cardioxyl Pharmaceuticals 59 INxin 59 Lixivaptan 59 optical biosensors 59 cannabinor 59 Bellicum 59 FOLOTYN ® 59 CYT# potent vascular disrupting 59 candidates Azedra TM 59 ophthalmic therapeutics 59 recombinant biopharmaceutical 59 unique PER.C6 59 neuroprotective properties 59 proprietary intranasal insulin 59 PHX# 59 Myolimus 59 treats acute lymphoblastic 59 non nucleoside HCV 59 novel immunotherapeutic 59 Sphingomab 59 TransVax tm 59 SMaRT ™ 59 ADP receptor antagonist 59 TRIOLEX HE# APOPTONE HE# 59 MT#/MEDI-# 59 proteasome inhibitor 59 KSP inhibitor 59 HuCAL PLATINUM 59 isoform selective 59 PI3K/Akt pathway inhibitor 59 ASONEP TM 59 stranded LNA 59 diagnostic molecular imaging 59 PANVAC VF 59 siRNA therapeutic 59 Receptos 59 clinically validated targets 59 Pyridorin 59 virus HCV protease inhibitor 59 Idera Pharmaceuticals 59 humanized therapeutic 59 HuCAL GOLD R 59 histone deacetylase HDAC 59 VentiRx 59 FOLFOX6 chemotherapy regimen 59 tiapamil 59 novel peptide 59 ASONEP ™ 59 exon skipping 59 novel antibody therapeutics 59 immunotherapeutic 59 Promedior 59 AFREZZA TM 59 CORT # 59 orally administered inhibitor 59 PDX pralatrexate 59 MKC# MT 59 HIV integrase inhibitor 59 anti amnesic 59 novel histone deacetylase 59 mertansine 59 ENMD # 59 ATRA IV 59 ATL# [002] 59 muscarinic receptor agonists 59 POTELLIGENT R 59 IMiDs ® compound 59 RECOTHROM R 59 cancer immunotherapies 59 Vilazodone 59 NEUGENE R 59 personalized cellular immunotherapy 59 subsidiaries visit http:/www.apricusbio.com 59 therapeutic monoclonal antibodies 59 accumulate preferentially 59 selective estrogen receptor modulator 59 GVAX ® 59 protein kinase inhibitors 59 Cotara ® 59 including eniluracil ADH 59 agonistic human 59 ospemifene 59 biobetter 59 Neulasta R 59 HepeX B TM 59 TRACON Pharmaceuticals 59 LX# LX# LX# 59 Receives Orphan Drug Designation 59 Nereus Pharmaceuticals 59 liposomal formulation 59 AEG# 59 Sangamo ZFP TF 59 PRT# 59 Panzem R 59 Presents Preclinical 59 developing Zerenex ferric 59 staphylococcal vaccine 59 Nventa proprietary CoVal 59 proprietary Dicer Substrate Technology 59 Generx TM 59 platforms GVAX 59 promising anticancer 59 Initiates Clinical Trial 59 TBC# 59 Marqibo TM 59 Trastuzumab DM1 58 Panzem R NCD 58 JAK inhibitor 58 Therapeutic Competitors Companies 58 mitogen activated ERK kinase 58 OXIGON 58 MassARRAY ® 58 highly selective endothelin 58 ocular formulation 58 KRN# 58 Mersana 58 systemic RNAi 58 AMPK activators 58 Depomed formulates 58 Receives Approvable Letter 58 Mpex 58 KAI Pharmaceuticals 58 Zalypsis 58 KL4 Surfactant 58 prostone 58 Cardium Therapeutics TM 58 Liprotamase 58 PEG irinotecan 58 Ostabolin C TM 58 nicotinic alpha 7 58 Profectus BioSciences 58 proprietary DuraSite ® 58 TRANSDUR ™ 58 allosteric modulation 58 NS5B polymerase 58 adenosine A2A 58 Intravenous CP 58 midstage trials 58 Telik logo TELINTRA 58 humanized monoclonal 58 Crofelemer budesonide foam 58 polysaccharide polymer 58 Sudhir Agrawal D.Phil 58 OvaRex R 58 Tarmogen 58 Initiates Phase III 58 2 methoxyestradiol 58 proprietary PEGylation 58 histone deacetylase HDAC inhibitor 58 Tikvah Therapeutics 58 fusion enhancers 58 Aileron Therapeutics 58 oral antiviral 58 Novavax VLP vaccine 58 proprietary dermal 58 small molecule glucokinase 58 SynCon ™ DNA 58 purinergic receptors P#X# 58 orally dosed 58 selective kinase inhibitor 58 DP VPA 58 Zemiva TM 58 Symadex 58 Pruvel TM 58 Submits Biologics License Application 58 vascular disrupting agents 58 Lipid Polymer Micelle LPM 58 Provectus Pharmaceuticals specializes 58 EndoTAG TM 58 tumor vascular disrupting 58 infectious diseases autoimmune 58 please visit http:/www.vandapharma.com 58 Pazopanib 58 delta opioid receptor 58 Nasulin TM 58 Anticalin R 58 pharmacological chaperone 58 Addrenex 58 GlycoPEGylated hemostasis compounds 58 GSK '# 58 Veronate R 58 peptidic compound 58 botulism antibody 58 Hsp# inhibition 58 kidney urologic 58 oncolytic 58 Inc. Nasdaq INFI 58 Present Preclinical Data 58 Nautilus Biotech 58 ophthalmology dermatology cardiovascular disease 58 QuatRx 58 ALN TTR# 58 FUSILEV ® 58 advanced polymer conjugate 58 rusalatide acetate 58 proprietary biomaterials 58 TELINTRA 58 small molecule PEGylation 58 mGluR5 antagonists 58 leading oral taxane 58 selective adenosine 58 drug pipeline TAFA# 58 Receives Milestone Payment 58 MTP inhibitor 58 product candidate Lpathomab 58 INS# [001] 58 Tyrima 58 phage display technology 58 AdVac 58 Acetylon 58 oncology therapeutics 58 punctal plug delivery 58 antiangiogenesis therapies 58 novel antifolate 58 AdVac ® 58 chemogenomics 58 bioengineers novel 58 gastro intestinal inflammation 58 PSN# [002] 58 ELADUR ™ 58 MCSP respectively 58 TKB# 58 patented NanoStat ™ 58 Relypsa 58 ALN PCS 58 phase IIa clinical 58 MSCRAMM ® 58 Hsp# Inhibitor 58 molecular chaperone regulation 58 Exherin 58 NU# direct 58 NuMimetic TM 58 BCR ABL inhibitors 58 ORTHOCON 58 cetuximab Erbitux R 58 non nucleoside inhibitor 58 HQK 58 investigational pharmacologically unique 58 M Enoxaparin 58 VentiRx Pharmaceuticals 58 ART# 58 SIX RO ROG 58 vinca alkaloid 58 oral ghrelin agonist 58 sapropterin dihydrochloride Phase 58 Antibody Drug Conjugate 58 delipidation 58 AFFITOME 58 antisense drug 58 novel therapeutic antibodies 58 IMiD 58 Chimigen TM 58 CEQ# 58 DPX Survivac 58 initiated Phase 1b 58 Pruvel ™ 58 HGS ETR1 mapatumumab 58 Elagolix 58 AFREZZA ® 58 OTCBB PYTO 58 targeted antifolate 58 KineMed 58 peripherally acting 58 Locus Pharmaceuticals 58 introduced NEUGENE 57 outlicensed 57 Cylene 57 Restoraderm 57 HyACT 57 IAP inhibitor 57 NP2 Enkephalin 57 PEGylated interferon 57 receptor modulators 57 Vascular Wrap TM 57 pan histone deacetylase 57 IMPACS R 57 selective androgen receptor modulator 57 proprietary polysaccharide 57 dasatinib Sprycel 57 Onalta ™ 57 Inc. AMEX YMI 57 immunotherapeutics 57 Orally administered 57 tubulin inhibitor 57 preclinically 57 Nasdaq ENZN 57 ActivX 57 Medarex UltiMAb 57 candidate XP# 57 Anidulafungin 57 PDE# 57 Kinaxo 57 Glucagon Like Peptide 57 CORT # estimates 57 ESBA# 57 Chemokine Therapeutics 57 evaluating tivozanib 57 Galenea 57 romazarit 57 Nutra Pharma wholly owned 57 Initiates Phase 2b 57 immunotherapeutic vaccine 57 Anchor Therapeutics 57 sterile lidocaine patch 57 Transdel TM platform 57 Additionally Soligenix 57 Targeted Chemotherapy 57 proprietary MSCRAMM protein 57 XL# XL# 57 AtuRNAi 57 AzaSite Xtra 57 Enhanze Technology 57 HEPLISAV ™ 57 TransVax ™ 57 R bortezomib 57 Blinatumomab 57 glucokinase activator 57 HuMax 57 Regado 57 TKM PLK1 57 product platforms GVAX 57 RONDEL TM 57 dimebon latrepirdine 57 GLPG# 57 Maribavir 57 Vaxfectin TM 57 ArQule Kinase Inhibitor Platform 57 Charlesson 57 Ridaforolimus 57 biased ligand 57 allogeneic cell 57 acetonide FA 57 Cintredekin Besudotox 57 Albugon 57 product platforms AZX# 57 neuropathic pain metabolic diseases 57 commercialize OncoGenex lead 57 infectious diseases autoimmune diseases 57 Quinamed 57 Catalyst Biosciences 57 epothilone 57 HuMax TF 57 diabetes irritable bowel 57 intranasal vaccines derived 57 AQUA ® 57 Aliskiren 57 Isis antisense 57 paclitaxel Taxol ® 57 Transdel ™ 57 bucindolol hydrochloride 57 vaccines oncolytic virus 57 proprietary BiTE ® 57 proprietary capillary aerosolization 57 using Crucell PER.C6 57 antiinfective 57 APC Targeting Technology 57 Apoptone HE# 57 vinorelbine tartrate 57 Davanat 57 ProMune 57 ProNAi 57 Cephalon Oncology 57 successfully commercialize Iluvien 57 platform HDL Mimetic 57 topically applied SEPA 57 PrevOnco 57 STEDESA 57 next generation URAT1 57 TRANSDUR ® 57 AVEO Pharmaceuticals 57 vosaroxin 57 Adenosine Therapeutics 57 Tesetaxel 57 EGEN 57 personalized immunotherapy 57 novel nucleoside analog 57 chemogenomic 57 HCV antiviral 57 RNA interference tkRNAi 57 TG# [003] 57 ALN HTT 57 Metallophile ™ Technology 57 Sapacitabine 57 TLR Therapeutics 57 generation nucleoside analog 57 Selzentry Celsentri 57 IG HCR ;) CO 57 MorphoSys proprietary 57 commercializing anti infective 57 R#/MEM # 57 HGS ETR2 57 MT# MEDI 57 Medarex UltiMAb R 57 Allovectin 7 57 non porcine pancreatic 57 Paramount BioSciences 57 cyclin dependent kinase CDK 57 candidate ATHX 57 novel VDA molecule 57 S1P antibody 57 semi synthetic lipoglycopeptide 57 topical anti infective 57 TBC M4 57 anti infective treatments 57 PF # [002] 57 Etubics 57 generation NEUGENE antisense 57 novel emulsion formulation 57 delivers sumatriptan 57 either acutely decompensated 57 Neo Kidney Augment 57 Hematide TM 57 ZARS Pharma 57 Panzem ® 57 REMOXY POSIDUR ELADUR 57 proprietary PharmacoSurgery TM 57 Astex 57 Dr. Aiping Young 57 Ad5FGF 4 57 Talabostat 57 peptide conjugated 57 Cyclosert 57 New Chemical Entities 57 Vidaza R 57 MKC# 57 ophthalmology oncology 57 Novartis NVS Snapshot Report 57 COMPLEGENT TM Technologies 57 Nektar PEGylation technology 57 DermaVir Patch 57 GeneICE 57 product Fentanyl TAIFUN 57 Successfully Completes Phase 57 oral proteasome inhibitor 57 molecular imaging pharmaceuticals 57 Nanobodies 57 Supernus 57 anionic backbone 57 antibiofilm 57 Indaflex 57 lipid nanoparticle 57 signal detection CTSD 57 patented Bioral 57 investigational monoclonal antibody 57 peptibody 57 Azedra TM 57 Cyclosert TM 57 Aurora Kinase 57 targets Galectin receptors 57 SMIP 57 HCV RNA polymerase 57 Mersana Therapeutics 57 Duromist ™ 57 HSP# inhibitor 57 mGluR2 NAM 57 Meets Primary Endpoint 57 Aegera 57 NeuroHealing 57 AVAX AC Vaccine 57 KNS # 57 SCIB1 57 IMiDs 57 proprietary Isolagen Process 57 Syndax Pharmaceuticals Inc. 57 HuCAL antibodies 57 PSN# [001] 56 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 56 Regado Biosciences 56 Wellstat 56 MP4 molecule 56 methylnaltrexone bromide 56 TLR8 agonist 56 Combivir Kivexa 56 ghrelin antagonist 56 immunotherapeutic agent 56 tkRNAi technology 56 gallium containing 56 oral dihydropyrimidine dehydrogenase DPD 56 Chrysalin 56 IMC A# 56 anti atherothrombotic 56 Vicriviroc 56 ZEVALIN ® 56 Trofex 56 XOMA 3AB biodefense 56 FoldRx 56 MorphoSys antibody 56 nilotinib Tasigna 56 modified glutathione analog 56 Vertex hepatitis C 56 Alferon N 56 JAK1 56 Surfaxin LS 56 Pervasis 56 chemical entities NCEs 56 NPC 1C 56 therapeutic peptide 56 Tarvacin TM 56 chimeric monoclonal antibody 56 patented NanoStat TM 56 RONDEL ™ 56 HuCNS SC ® 56 HCV protease inhibitors 56 proprietary transdermal 56 please visit www.medicinova.com 56 novel antiviral therapeutics 56 thalidomide Thalomid 56 AVEO Pharmaceuticals NASDAQ 56 Nanobody R 56 NASDAQ INFI 56 Romidepsin 56 small molecule thrombopoietin 56 OncoVex 56 clinical trials Archexin 56 prokinetic agent 56 Cerimon 56 targeted anticancer biopharmaceuticals 56 histone deacetylase inhibitor 56 CD# CEA 56 novel BiTE antibodies 56 targets HGF FGFR 56 UltiMAb ® 56 therapeutic antibody 56 miRNA biomarkers 56 includes TOLAMBA TM 56 indibulin 56 KYTHERA 56 FoldRx Pharmaceuticals Inc. 56 humanized monoclonal antibodies 56 Ceflatonin R 56 dasatinib Sprycel ® 56 SARMs 56 Bioral Amphotericin B. 56 HCV NS5B polymerase 56 SIMPLE Antibody TM 56 PrevOnco ™ 56 Marillion Pharmaceuticals 56 Nexavar sorafenib tablets 56 HuCAL PLATINUM ® CysDisplay 56 pan HDAC inhibitor 56 Sirion Therapeutics 56 cathepsin K inhibitor 56 Ketotransdel TM 56 anticoagulant reversing agent 56 NYSE Amex AEN 56 EHT AGN 56 PEGylated 56 RNA antagonists 56 comprise Alnylam RNAi 56 highly selective adenosine 56 drug conjugates ADCs 56 small molecule 56 pharmacodynamic profile 56 Solulin 56 HCD# [002] 56 Nasdaq PARD biopharmaceutical 56 geldanamycin 56 generation PNP inhibitor 56 2A receptor agonist 56 rALLy clinical trial 56 TRO# 56 biomodulator 56 PEG SN# 56 POTELLIGENT R Technology 56 Fludara ® 56 EGS# 56 Dicer Substrate Technology 56 OTCBB HXBM developer 56 Carfilzomib 56 REG2 Regado 56 personalized dendritic 56 pralatrexate injection folate analogue 56 Innovive Pharmaceuticals 56 activate SIRT1 56 acyclovir Lauriad R 56 Enhanze TM Technology 56 basal insulin analogue 56 pipeline ImmunoGen collaborators 56 dipeptidyl peptidase IV 56 Prodarsan R 56 Tesmilifene 56 Lipocine 56 Kinase Inhibitor 56 selective A2A adenosine receptor 56 vaccine GRNVAC1 56 IgG1 monoclonal antibody 56 novel topoisomerase 56 eligen R technology 56 PAION AG ISIN 56 CB2 receptor selective 56 antibody fragment therapeutics 56 novel RNAi therapeutics 56 IMC #B 56 Phase IIb clinical trials 56 siRNA therapeutics 56 NASDAQ INGN 56 proteomic bioinformatic 56 NNRs 56 ThermoDox R 56 MDRNA proprietary 56 delivers fluocinolone acetonide FA 56 Epitomics 56 Ketotransdel 56 TARIS Biomedical 56 Omacetaxine 56 Amplimexon 56 class mGluR5 inhibitor 56 telomerase therapeutic 56 AeroLEF R 56 epigenetic therapies 56 targeting Inflammatory Bowel 56 Alnylam RNAi 56 potently inhibit 56 ChronVac C R 56 Submits Supplemental 56 Luteinizing Hormone Releasing Hormone 56 Delafloxacin 56 EZN 56 proteasome inhibitors 56 small molecule agonists 56 Genedata Expressionist ® 56 DXL# 56 Medarex applies 56 Hybridon 56 Gemin X 56 Staccato nicotine technology 56 DepoVax ™ 56 treating neuropathic pain 56 PRNewswire FirstCall Neurogen 56 Synavive 56 Aradigm Logo 56 5 HT2C serotonin 56 inhibitor PPI 56 Immunotope 56 protein receptors lectins 56 Empatic TM 56 cyclophilin inhibitors 56 phase IIb clinical 56 Zelos Therapeutics 56 HyperAcute 56 Syrrx 56 zolpidem tartrate sublingual tablet 56 ALN TTR 56 indications Cytokinetics 56 Salmedix 56 JAK2 Inhibitor 56 Novel Oral 56 telomerase inhibitor drug 56 Bicifadine 56 lipopeptide 56 systemic RNAi therapeutic 56 Nasdaq RDEA 56 tumor activated prodrug 56 ibudilast 56 RxKinetix 56 Kalypsys 56 stable nucleic acid 56 novel orally administered 56 Calistoga Pharmaceuticals 56 Versartis 56 Apo AIMilano 56 Juvaris BioTherapeutics 56 Friedreich Ataxia FRDA 56 generation antisense 56 ChemoCentryx 56 RetroMetabolic Drug Design 56 vemurafenib 56 midstage clinical 56 proven proprietary Acuform 56 5 HT2A inverse 56 Intarcia 56 neuronal nicotinic receptor NNR 56 DNA methyltransferase inhibitors 56 refractory chronic lymphocytic 56 ® bortezomib 56 RNA therapeutics 56 5 HT6 receptor 56 AFFITOME R 56 Novosom 56 kinase profiling 56 PEGylated docetaxel 56 preclinical compounds 56 inhibit KSP 56 fluorinated carbohydrate mimics 56 novel peptides 56 Empatic ™ 56 ChromoCure develops 56 5 HT2A serotonin 56 XOMA 3AB 56 Nicotine Conjugate Vaccine 56 CTLA4 Ig 56 Amgen discovers develops 56 palonosetron hydrochloride Injection Dacogen 56 NEUGENE 56 SYN# 56 Mipomersen 56 nucleoside analog 56 AdVac R 56 London AiM GLPG 56 HuCAL 56 potentially treat nephropathic 56 Aptamer 56 Achieves Primary Endpoint 56 negative allosteric modulator 56 Submits NDA 56 Viprovex TM 56 Files Investigational 56 Serdaxin 56 Kiadis 56 carbohydrate polymer 56 DNAi 56 anti secretory 56 MGd 56 5 HT6 antagonist 56 demonstrated antitumor activity 56 Odyssey Thera 56 Restoraderm R technology 56 Like Receptor 56 XP# XP# 56 neurology immunology 55 Arno Therapeutics 55 imexon 55 bortezomib Velcade R 55 androgen receptor antagonist 55 Cx# [002] 55 Aurora kinase inhibitor 55 Phase 2b clinical trials 55 Xcellerated T Cells 55 novel orally bioavailable 55 GED aPC 55 Solazed 55 Multimeric 55 CDK cyclin dependent 55 covering SNALP 55 Drug Candidate 55 investigational compounds 55 generation URAT1 inhibitor 55 developing Bicifadine serotonin 55 small molecule Hedgehog 55 immunological diseases 55 antibody humanization 55 TLR8 55 KL4 surfactant 55 preclinical efficacy 55 developing ACAPODENE 55 NanoTab 55 Glypromate 55 mitiglinide 55 Excellarate TM 55 Amgen Kyowa Hakko Kirin 55 adecatumumab MT#